UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
Amendment No. 1
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2009
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission file number 1-11353
LABORATORY CORPORATION OF
AMERICA HOLDINGS
(Exact name of registrant as specified in its charter)
|
Delaware |
|
13-3757370 |
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
358 South Main Street, |
|
|
|
Burlington, North Carolina |
|
27215 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(Registrant's telephone number, including area code) 336-229-1127
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject
to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer [X] |
Accelerated Filer [ ] |
|
Non-accelerated filer [ ] (Do not check if a smaller reporting company) |
Smaller reporting company [ ] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X].
The number of shares outstanding of the issuer's common stock is 108.3 million shares, net of treasury stock as of July 30, 2009.
EXPLANATORY NOTE
The sole purpose of this Amendment No. 1 on Form 10-Q/A to Laboratory Corporation of America Holdings’ Form 10-Q for the quarterly period ended June 30, 2009 (the “Form 10-Q”) is to furnish the interactive data files as exhibit 101. Exhibit 101 to this report provides the following items from
the Company’s Form 10-Q formatted in Extensible Business Reporting Language (XBRL): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Operations, (iii) the unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity, (iv) the unaudited Condensed Consolidated Statements of Cash Flows and (v) the Notes to unaudited Condensed Consolidated Financial Statements, tagged as blocks of text.
Users of this data are advised that pursuant to Rule 406T of Regulation S-T these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, are deemed not filed for purposes of section 18 of the Securities and
Exchange Act of 1934, and otherwise are not subject to liability under those sections. No other changes have been made to the Form 10-Q other than those described above. This Amendment No. 1 does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way disclosures made in the Form 10-Q.
Exhibit Index
|
Exhibit |
|
|
|
Number |
|
Description |
|
12.1* |
|
Ratio of earnings to fixed charges |
|
31.1* |
|
Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) |
|
31.2* |
|
Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) |
|
32* |
|
Written Statement of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) |
|
101.INS** |
|
XBRL Instance Document |
|
101.SCH** |
|
XBRL Taxonomy Extension Schema |
|
101.CAL** |
|
XBRL Taxonomy Calculation Linkbase |
|
101.DEF** |
|
XBRL Taxonomy Extension Definition Linkbase |
|
101.LAB** |
|
XBRL Taxonomy Extension Label Linkbase |
|
101.PRE** |
|
XBRL Taxonomy Extension Presentation Linkbase |
|
* |
|
previously filed |
|
** |
|
filed herewith |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant
| |
By: |
/s/ DAVID P. KING |
| |
|
David P. King |
| |
|
President and Chief Executive Officer |
| |
By: |
/s/ WILLIAM B. HAYES |
| |
|
William B. Hayes |
| |
|
Executive Vice President, |
| |
|
Chief Financial Officer and Treasurer |
August 28, 2009
4